Suppote Pheanant Atarmateuticals is evaluativg a proposed coptal bodgeting project (project Beta) that will require ant inalial Iniestinent of 43,000,000. The project is exgected to generate the following met cash fions: Eheasant Pharmactevicalsk weighted average cost of capkai is 9%, and project beta has the same risk as the firm average preject. Baied en the cash thowh, what is preject Beta's sive 11,204,53451,579,58452,015,50111,354,564 Haking the accept or reject decisisn finted, it shourd prostat beta. asesterit